13:55:38 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2023-11-07 15-10 2023-Q3
2023-08-16 Kvartalsrapport 2023-Q2
2023-05-03 15-10 2023-Q1
2023-03-09 Ordinarie utdelning DEMANT 0.00 DKK
2023-03-08 Årsstämma 2023
2023-02-07 Bokslutskommuniké 2022
2022-11-09 15-10 2022-Q3
2022-08-16 Kvartalsrapport 2022-Q2
2022-05-03 15-10 2022-Q1
2022-03-11 Ordinarie utdelning DEMANT 0.00 DKK
2022-03-10 Årsstämma 2022
2022-02-08 Bokslutskommuniké 2021
2021-08-12 Kvartalsrapport 2021-Q2
2021-03-08 Ordinarie utdelning DEMANT 0.00 DKK
2021-03-05 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-08-17 Kvartalsrapport 2020-Q2
2020-03-11 Ordinarie utdelning DEMANT 0.00 DKK
2020-03-10 Årsstämma 2020
2020-02-04 Bokslutskommuniké 2019
2019-08-14 Kvartalsrapport 2019-Q2
2019-03-20 Ordinarie utdelning DEMANT 0.00 DKK
2019-03-19 Årsstämma 2019
2019-02-19 Bokslutskommuniké 2018
2018-08-15 Kvartalsrapport 2018-Q2
2018-03-23 Ordinarie utdelning DEMANT 0.00 DKK
2018-03-22 Årsstämma 2018
2018-02-22 Bokslutskommuniké 2017
2017-08-14 Kvartalsrapport 2017-Q2
2017-05-09 Kvartalsrapport 2017-Q1
2017-03-28 Ordinarie utdelning DEMANT 0.00 DKK
2017-03-27 Årsstämma 2017
2017-02-23 Bokslutskommuniké 2016
2016-11-10 Kvartalsrapport 2016-Q3
2016-08-17 Kvartalsrapport 2016-Q2
2016-05-25 Split DEMANT 1:5
2016-05-10 Kvartalsrapport 2016-Q1
2016-04-08 Ordinarie utdelning DEMANT 0.00 DKK
2016-04-07 Årsstämma 2016
2016-03-01 Bokslutskommuniké 2015
2015-11-12 Kvartalsrapport 2015-Q3
2015-08-14 Kvartalsrapport 2015-Q2
2015-05-07 Kvartalsrapport 2015-Q1
2015-04-10 Ordinarie utdelning DEMANT 0.00 DKK
2015-04-09 Årsstämma 2015
2015-02-26 Bokslutskommuniké 2014
2014-04-10 Ordinarie utdelning DEMANT 0.00 DKK
2013-04-10 Ordinarie utdelning
2012-04-12 Ordinarie utdelning DEMANT 0.00 DKK
2011-04-14 Ordinarie utdelning
2010-04-08 Ordinarie utdelning

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
Demant är verksamma inom medicinteknik. Bolaget är specialiserade inom utveckling av hörapparater och hörslingor. Idag innehar bolaget verksamhet på global nivå där produkterna säljs under varierande varumärken. Produkterna nås via bolagets distributörer och försäljningskanaler. Utöver huvudverksamheten bedriver bolaget forskning inom diagnostik för mätning av hörselkvalitén. Bolaget grundades ursprungligen under 1904 och har sitt huvudkontor i Smörum.
2022-03-04 06:51:25

4.3.2022 06:51:24 CET | Demant A/S | Inside information

Company announcement no 2022-05                                  4 March 2022

 

Investment in leading growth platform in China

 

Demant has completed the acquisition of 20% of the shares in ShengWang, a leading network of hearing aid clinics in China with around 500 shops across the country. The investment allows Demant to further strengthen its position in the large, fast-growing Chinese hearing aid market where ShengWang has high ambitions for continued expansion. With a strong leadership team, a proven organisation and scalable processes, ShengWang offers an excellent growth platform for the next many years.

 

Demant and ShengWang are working in close collaboration to complete a transaction regarding the acquisition of the remaining 80% of ShengWang before the end of H1 2022 at which point details of the financial impact of the transaction will be disclosed.

 

ShengWang was founded in 1998 and has for several years – and particularly following the introduction of Philips Hearing Solutions – been a valued partner of the Demant Group thanks to a strong relationship with our Hearing Aids business. Today, ShengWang has more than 1,300 employees serving the fast-growing Chinese market for hearing care, which is expected to see double-digit annual growth rates in the next many years due to demographic developments and a gradually increasing penetration rate.

 

As part of the investment in ShengWang, Niels Wagner, President of Demant’s Hearing Care business, has joined the company’s board of directors.

 

In itself, the completed acquisition of 20% of the shares in ShengWang will only have a very limited financial impact on the Group, and the Group’s outlook for 2022 thus remains unchanged. Completion of the planned full acquisition of ShengWang will entail full financial consolidation, and as stated above, the financial impact of such consolidation will be disclosed upon closing of the transaction.

 

 

Further information:

Søren Nielsen, President & CEO

Phone +45 3917 7300

www.demant.com

Other contacts:

René Schneider, CFO

Mathias Holten Møller, Head of Investor Relations

Peter Pudselykke, Investor Relations Officer

Trine Kromann-Mikkelsen, VP Corporate Communications and Relations

 

 

About Demant A/S

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.

Attachments